Organic Sales Growth Despite Disruption
Q1 organic net sales growth of 2.4% worldwide, with 1.9% growth in the U.S. and 3.9% internationally. Management emphasized underlying demand remained healthy across businesses despite the cyber incident.
Full-Year Guidance Reaffirmed
Company maintained full-year 2026 guidance: expected organic net sales growth of 8.0%–9.5% and adjusted net EPS of $14.90–$15.10, reflecting confidence that most lost Q1 sales will be realized over the remainder of the year.
Rapid Operational Recovery from Cyber Incident
As of the week of April 1, global manufacturing network was fully operational. Management reported successful removal of unauthorized party, restoration from backups, and prioritized patient care during recovery.
Record Mako Installations and Strong Robotic Momentum
Delivered best-ever Q1 for Mako installations in the U.S. and internationally with rising utilization rates. Mako Shoulder feedback positive and full launch on Mako 4 expected mid-year. New RPS handheld receiving strong early customer feedback.
Strategic Reorganization and Product Integration
Established new Ortho Tech business by combining Mako and Enabling Technologies with Orthopaedic Instruments to simplify customer experience, accelerate innovation and speed to market; segment disclosures updated accordingly.
M&A Activity and Pipeline
Announced agreement to acquire Amplitude Vascular Systems (expected to close in Q2) to expand peripheral vascular/cardiovascular offerings; management signaled active M&A pipeline and capacity to deploy capital (gross debt/EBITDA ~2.1x at quarter end).
Key Product Approvals and International Rollouts
Pangea received approval in Europe (and Japan earlier), LIFEPAK approvals in Europe; management expects Pangea and LIFEPAK to drive above-market growth internationally as production ramps.
Financial and Tax Positioning
Q1 adjusted effective tax rate was 14.5%; full-year 2026 effective tax rate expected 15%–16%. YTD cash from operations of $581M; company expects free cash flow conversion in the ~70%–80% range and maintained adjusted other income & expense full-year expectation of ~$420M.
Smart Hospital Launch
Launched Smart Hospital by combining Vocera and care.ai into SmartCare unit to provide integrated solutions (positive early customer feedback reported).